OX40/TNFRSF4 Antibody (vonlerizumab) [Janelia Fluor™ 585], Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB527134-Each-of-1 | In Stock | ₹ 33,747.02 |
NB527134 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 33,747.02
GST (18%): ₹ 6,074.464
Total Price: ₹ 39,821.484
Antigen
OX40/TNFRSF4
Classification
Monoclonal
Conjugate
Janelia Fluor 585
Gene Alias
ACT35 antigen, ACT35ATC35 antigen, CD134, CD134 antigen, OX40 cell surface antigen, OX40 homologue, OX40L receptor, OX40lymphoid activation antigene ACT35, TAX transcriptionally-activated glycoprotein 1 receptor, tax-transcriptionally activated glycoprotein 1 receptor, tumor necrosis factor receptor superfamily member 4, tumor necrosis factor receptor superfamily, member 4, TXGP1LOX40 antigen
Immunogen
TNFRSF4/ OX40/ CD134
Quantity
0.1 mL
Research Discipline
Adaptive Immunity, B Cell Development and Differentiation Markers, Cancer, Cell Cycle and Replication, Immunology, Myeloid derived Suppressor Cell, Signal Transduction
Gene ID (Entrez)
7293
Content And Storage
Store at 4°C in the dark.
Isotype
IgG1
Applications
Flow Cytometry, ELISA, Functional Assay
Clone
vonlerizumab
Formulation
50mM Sodium Borate
Host Species
Human
Purification Method
Protein A purified
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Human
Form
Purified
Related Products
Description
- OX40/TNFRSF4 Monoclonal antibody specifically detects OX40/TNFRSF4 in Human samples
- It is validated for Flow Cytometry,ELISA,Functional Assay